Continuous Access



  • Timely management of post-approval commitments (registries, budget caps)
  • Real World Evidence generation to support maintenance/improvement of reimbursement conditions
  • Landscape analysis and definition of strategies in preparation of competitor entry
  • Management of the pharmaceutical payback process: evaluation of the impact on the company portfolio; definition and implementation of strategies/actions to protect portfolio; interaction with the authorities on baseline data, and methodologies applied